ClinicalTrials.gg
Active, not recruitingNCT06687525Updated May 4, 2026

Alcohol and the Social Brain: An Alcohol-Administration Hyperscanning Study

An observational study in Alcohol Drinking, Alcohol Use Disorder and Alcohol Intoxication, sponsored by University of Illinois at Urbana-Champaign. Active, not recruiting at 1 site in United States. Open to participants aged 21 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-04.

Primary conditionAlcoholismRegistry: Alcohol DrinkingReclassifiedWhy we changed it
Registry
Alcohol Drinking — the first condition term the registry derived for this study.
ClinicalTrials.gg
Alcoholism
Why
  1. Alcohol Drinking is a broad heading, used only when no more specific condition is named.
  2. The study's listed conditions name Alcoholism.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by University of Illinois at Urbana-Champaign · Observational

Study type
Observational
Model
Other
Time perspective
Other
Enrollment
240
Ages
21 Years to 30 Years
Sex
All
01

Study summary

In this study, the investigators aim to capture inter- and intra-brain mechanisms underlying alcohol reward in novel social context.

Read the detailed description

Objective: Alcohol's ability to boost mood in the face of stress is perhaps its most notoriously addictive property, long held by researchers to be of critical importance for understanding alcohol use disorder (AUD) etiology. Yet, while most real-world alcohol consumption occurs in social settings, in the context of laboratory studies, participants have almost always consumed alcohol alone. The discrepancy between real-world and laboratory contexts emerges as particularly stark in the neuroimaging literature, where no alcohol-administration study to date has incorporated in-vivo social context. In this first alcohol-administration study to leverage EEG hyperscanning methods, the investigators aim to capture inter- and intra-brain mechanisms underlying alcohol reward in novel social context.

Specifically, this study aims to characterize the mechanisms driving social reward from alcohol in the context of stress and elucidate the role of social processes and novel social context in driving problem drinking.

Study Population: Participants will consist of 240 regular drinkers, aged 21-30, with no reported history of severe alcohol use disorder.

Design: In the laboratory arm of the study, individuals will be randomly assigned to consume either a moderate dose of alcohol or a control beverage in stranger dyads. Participants will engage in both structured and unstructured tasks aimed at assessing social engagement and threat sensitivity. EEG and ERP data will be collected from both participants simultaneously. In the ambulatory study arm, participants will wear transdermal sensors to assess BAC and will further provide information about their mood and their social contexts in response to random prompts.

Outcome Measures: Primary outcome measures include EEG measures of inter-brain entrainment as well as ERP metrics derived from task contexts (both players and observers). Additional outcomes include measures of positive mood, negative mood, and social bonding. Finally, drinking behaviors will be assessed via transdermal ambulatory alcohol sensors and longitudinal self-reports of drinking.

02

Conditions studied

  • Alcohol Drinking
  • Alcohol Use Disorder
  • Alcohol Intoxication
  • Alcohol; Harmful Use
  • Alcoholism
  • Binge Drinking

Browse trials for

03

In context

Alcoholism Reclassified

1,674 studies on the registry are indexed under Alcoholism; 331 are open to participants now.

This study's planned enrollment of 240 is above the median of 159 across 183 observational studies indexed under Alcoholism.

Browse Alcoholism studies →

Lead sponsor

University of Illinois at Urbana-Champaign is the lead sponsor of 191 studies on the registry; 29 are open to participants now.

Compared within Alcoholism, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Alcohol Drinking. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
21 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Healthy regular drinkers aged 21-30

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Between the ages of 21 and 30
  • Regularly consumes alcohol

Exclusion criteria

Exclusion Criteria:

  • History of adverse reaction to the amount of beverage employed in the study
  • Have a history of major problems associated with alcohol
  • Take medications that could adversely interact with alcohol
  • Have medical conditions that contraindicate alcohol administration
  • Individuals with a history of skull fractures or who indicate discomfort with EEG procedures used
  • Female participant is pregnant or trying to become pregnant
05

Study design

Observational model
Other
Time perspective
Other
Enrollment
240 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Inter-brain entrainment

    The association between dyad-members EEG signals during the hyperscanning task

    Time frame: During active laboratory beverage manipulation exposure (during or immediately after beverage administration, at which time participants in the alcohol condition will register a positive BAC)

  2. Feedback-related negativity

    An ERP component calculated from a time-estimation task

    Time frame: During active laboratory beverage manipulation exposure (during or immediately after beverage administration, at which time participants in the alcohol condition will register a positive BAC)

  3. Ambulatory Drinking

    Drinking behavior assessed outside the laboratory using ambulatory assessment

    Time frame: 14 days

  4. Longitudinal Drinking Problems

    Drinking assessed at longitudinal follow-up

    Time frame: Up to 24 months post-baseline

07

Study locations

1 site
08

References and documents

Publications

  • Sayette MA, Creswell KG, Dimoff JD, Fairbairn CE, Cohn JF, Heckman BW, Kirchner TR, Levine JM, Moreland RL. Alcohol and group formation: a multimodal investigation of the effects of alcohol on emotion and social bonding. Psychol Sci. 2012 Aug 1;23(8):869-78. doi: 10.1177/0956797611435134. Epub 2012 Jul 3. PubMed 22760882 ↗
  • Fairbairn CE, Sayette MA. A social-attributional analysis of alcohol response. Psychol Bull. 2014 Sep;140(5):1361-82. doi: 10.1037/a0037563. PubMed 25180806 ↗
  • Fairbairn CE, Kang D, Federmeier KD. Alcohol and Neural Dynamics: A Meta-analysis of Acute Alcohol Effects on Event-Related Brain Potentials. Biol Psychiatry. 2021 May 15;89(10):990-1000. doi: 10.1016/j.biopsych.2020.11.024. Epub 2020 Dec 11. PubMed 33579536 ↗

Individual participant data

Plan to share: Yes — Data is being shared on the National Institute of Mental Health Data Archive

Data sharing details ↗ · nda.nih.gov

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06687525
Responsible party
Sponsor
First posted
Nov 13, 2024
Start date
Apr 5, 2024
Primary completion
Jan 26, 2026
Completion
Jun 1, 2028 (estimated)
Last update
May 4, 2026

Study contacts

Catharine E Fairbairn, Ph.D.
principal investigator · University of Illinois at Urbana-Champaign

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion